Saturday, February 21, 2026
21.7 C
Bengaluru

Winning Sales Organization

[wpfilebase tag=file id=101 tpl=download-button /]

Inside this Issue

1. Rudyard Kipling and the Pharma Brand Plan  by  Vivek Hattangadi

The wisdom of the renown English poet applied to pharma brand planning

2. What Does Digitilization Mean to You? by Hanno Wolfram

A look at the impact of digital at every step of the healthcare value chaint 

3. Selling in a Digital Era by Salil Kallianpuri

The right message, to the right customer, at the right frequency, through the right channels 

4. OPPI 51 AGM Highlights  by K. Hariram

Reporting

5. AIOCD Market Highlights  by Ameesh Masurekar

Market highlights for the month of November 2017

Download the issue here: PDF

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img